EP Patent

EP0330284B1 — Process for the preparation of a pharmaceutical granulate

Assigned to Astellas Pharma Europe BV · Expires 1994-07-27 · 32y expired

What this patent protects

A wet granulate is provided containing a therapeutically useful substance having a water solubility 10 wt% or less and microcrystalline or microfine cellulose or a mixture of both, characterised in that substantial amounts of wet binders are avoided. Tableting mixtures with the…

USPTO Abstract

A wet granulate is provided containing a therapeutically useful substance having a water solubility 10 wt% or less and microcrystalline or microfine cellulose or a mixture of both, characterised in that substantial amounts of wet binders are avoided. Tableting mixtures with the new granulate possess a good flow pattern and may be compressed to tablets which show an excellent disintegration behaviour.

Drugs covered by this patent

Patent Metadata

Patent number
EP0330284B1
Jurisdiction
EP
Classification
—
Expires
1994-07-27
Drug substance claim
No
Drug product claim
No
Assignee
Astellas Pharma Europe BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.